FTC Pulls Back From Prior Support for Pharmacy Benefit Middlemen
Newswire
“Corners are cut to dispense prescriptions,” CVS employee tells Ohio Board of Pharmacy
How UHC’s acquisition of a popular Medicare Adv. algorithm sparked internal dissent over denied care
‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
Your Drug Rebate Check Is in the Mail…to Switzerland
Another Dispatch From the Accumulator-Maximizer Wars
State Insurance Commissioners Seek Meeting With FTC On PBMs
How to Fix the National Drug Shortage
Bipartisan support on key panel for crackdown on pharmaceutical middlemen
Policing prescription-drug middlemen’s middlemen
Denials of health-insurance claims are rising — and getting weirder
Patients Often Lose in the Battle between Pharma and PBMs
PBM landscape in for a shakeup
Report: “Specialty” drugs are by far the most expensive, but classification seems arbitrary
Health Insurance Claim Denied? See What Insurers Said Behind the Scenes
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
Will Senate Hearing Expose PBMs’ Unscrupulous Drug Pricing Tactics?
Patients Lose Access to Free Medicines Amid Spat Between Drugmakers, Health Plans
Another powerful congressional committee is ready to take on PBMs
Bipartisan Senate plan would regulate PBM compensation, target ‘unfair’ drug price hikes
We Need Your Support Today!